Skip to main content
. 2018 Sep 20;7(19):e010203. doi: 10.1161/JAHA.118.010203

Figure 1.

Figure 1

Distributions of various guideline‐directed medications and therapies, stratified by black and white patients hospitalized with non–ST‐segment–elevation myocardial infarction. ACEi indicates angiotensin‐converting enzyme inhibitor; ARB, angiotensin II receptor blocker.